Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique challenges in pain-insensitive individuals.

Patient Safety Issues With Patient-Controlled Analgesia . Yvonne D'Arcy, MS, ... Cite this: Patient Safety Issues With Patient-Controlled Analgesia - Medscape - Jun 26, 2007. Abstract; ...

Remifentanil patient controlled analgesia (RPCA) is a short-acting pain reliever, an opiate, similar to pethidine. It relieves pain rapidly, but also wears off very quickly, ...

Patient controlled analgesia in the emergency department is effective. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2015 / 06 / 150622101044.htm ...

Remifentanil patient controlled analgesia (RPCA) is a short-acting pain reliever, an opiate, similar to pethidine. It relieves pain rapidly, but also wears off very quickly, which makes it very ...

The market for patient-controlled analgesia pumps is anticipated to reach US$ 421.9 million in 2022 and grow at a CAGR of 5.2% to US$ 699.9 million by 2032. PCA pumps will dominate the market globally ...

Portland, OR, Feb. 24, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global patient controlled analgesia pumps market was estimated at $277.67 million ...

Bryanne Patail, biomedical engineer at the U.S. Department of Veterans Affairs, National Center for Patient Safety, discusses patient-controlled analgesia (PCA) pumps and what the Veterans Health ...

The Physician-Patient Alliance for Health & Safety has released the results of its first national survey of patient-controlled analgesia practices. Patient controlled analgesia is known to result ...

The Physician-Patient Alliance for Health and Safety gave safety recommendations for patient-controlled analgesia pumps to manage pain, according to The Sacramento Bee.

Patient-Controlled Analgesia Needs Safety Improvements The recently released Consumer Reports’ Hospital Ratings suggests a need to reduce hospital-caused patient harm, as only 158 out of 1,000 ...

In a study to be presented on Feb. 7 at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in New Orleans, researchers will report findings which suggest remifentanil ...